weight loss

FDA warns about fake Ozempic, how to spot it
The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic prescriptions.
SPONSORED: Bariatric surgery can be major step in solving infertility
Proposal to let Medicare, Medicaid cover anti-obesity drugs halted
Trump, RFK Jr. go after antidepressants and weight loss drugs
SPONSORED: Benefits of bariatric surgery also extend to emotional health
FDA approves 1st medication for obstructive sleep apnea
US obesity rates drop for 1st time in a decade
More Stories
Action News Investigation: How potent are online weight loss meds?
Jelly Roll's chef opens up about singer's 100-pound weight loss
Ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's: Study
Weight loss drugs like Ozempic may help reduce overdose risks: Study
Ozempic producer CEO in hot seat in congressional hearing
Obesity prevalence among US adults falls slightly to 40%: CDC
Eli Lilly to sell Zepbound directly to consumers without insurance
Some people are overdosing on semaglutide, FDA warns
Nearly half of US adult cancer deaths could be prevented, study finds
Pfizer targets obesity with new once-daily Danuglipron drug
Weight-loss, diabetes meds linked to lower risk of some cancers: Study
Eli Lilly warns about dangers of fake Mounjaro, Zepbound
Show More
Show Fewer
More Stories
SPONSORED: Bariatric surgery can be major step in solving infertility
Proposal to let Medicare, Medicaid cover anti-obesity drugs halted
Trump, RFK Jr. go after antidepressants and weight loss drugs
SPONSORED: Benefits of bariatric surgery also extend to emotional health
FDA approves 1st medication for obstructive sleep apnea
US obesity rates drop for 1st time in a decade
Action News Investigation: How potent are online weight loss meds?
Jelly Roll's chef opens up about singer's 100-pound weight loss
Ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's: Study
Weight loss drugs like Ozempic may help reduce overdose risks: Study
Ozempic producer CEO in hot seat in congressional hearing
Obesity prevalence among US adults falls slightly to 40%: CDC
Eli Lilly to sell Zepbound directly to consumers without insurance
Some people are overdosing on semaglutide, FDA warns
Nearly half of US adult cancer deaths could be prevented, study finds
Pfizer targets obesity with new once-daily Danuglipron drug
Weight-loss, diabetes meds linked to lower risk of some cancers: Study
Eli Lilly warns about dangers of fake Mounjaro, Zepbound
Show More
Show Fewer